{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:38:49Z","timestamp":1792820329305,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020419","name":"Cure CMD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omtn.2024.102178","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T01:11:12Z","timestamp":1711156272000},"page":"102178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-451X","authenticated-orcid":false,"given":"Astrid","family":"Brull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Sarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Bolduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley M.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten G.","family":"B\u00f6nnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102178_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2011.81","article-title":"The collagen VI-related myopathies: Muscle meets its matrix","volume":"7","author":"B\u00f6nnemann","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtn.2024.102178_bib2","first-page":"435","article-title":"Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen","volume":"42","author":"Weil","year":"1988","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2024.102178_bib3","doi-asserted-by":"crossref","first-page":"18601","DOI":"10.1016\/S0021-9258(18)37327-7","article-title":"Amino acid sequence of the triple-helical domain of human collagen type VI","volume":"263","author":"Chu","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102178_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.1990.tb17917.x","article-title":"The Structure of Type VI Collagen","volume":"580","author":"Chu","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.omtn.2024.102178_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1083\/jcb.102.3.703","article-title":"Molecular assembly, secretion, and matrix deposition of type VI collagen","volume":"102","author":"Engvall","year":"1986","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2024.102178_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/bj2110303","article-title":"Electron-microscopical approach to a structural model of intima collagen","volume":"211","author":"Furthmayr","year":"1983","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtn.2024.102178_bib7","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.1074\/jbc.273.13.7423","article-title":"The role of the alpha3(VI) chain in collagen VI assembly. Expression of an alpha3(VI) chain lacking N-terminal modules N10-N7 restores collagen VI assembly, secretion, and matrix deposition in an alpha3(VI)-deficient cell line","volume":"273","author":"Lamand\u00e9","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102178_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.actbio.2016.12.023","article-title":"Defining the hierarchical organisation of collagen VI microfibrils at nanometre to micrometre length scales","volume":"52","author":"Godwin","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.omtn.2024.102178_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-2836(03)00585-0","article-title":"The supramolecular organization of collagen VI microfibrils","volume":"330","author":"Baldock","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102178_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/hmg\/ddi025","article-title":"Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy","volume":"14","author":"Baker","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102178_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ana.22087","article-title":"Early onset collagen VI myopathies: Genetic and clinical correlations","volume":"68","author":"Bri\u00f1as","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2024.102178_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124403","article-title":"A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies","volume":"4","author":"Bolduc","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2024.102178_bib13","first-page":"1","article-title":"Improving genetic diagnosis in Mendelian disease with transcriptome sequencing Genotype-Tissue Expression Consortium","volume":"5209","author":"Cummings","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2024.102178_bib14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/humu.20704","article-title":"Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance","volume":"29","author":"Lampe","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2024.102178_bib15","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/humu.22429","article-title":"Position of glycine substitutions in the triple helix of COL6A1, COL6A2, and COL6A3 is correlated with severity and mode of inheritance in collagen vi myopathies","volume":"34","author":"Butterfield","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2024.102178_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jmg.2002.002311","article-title":"Collagen VI related muscle disorders","volume":"42","author":"Lampe","year":"2005","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtn.2024.102178_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.21439","article-title":"Collagen VI glycine mutations: Perturbed assembly and a spectrum of clinical severity","volume":"64","author":"Pace","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2024.102178_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/377107","article-title":"New Molecular Mechanism for Ullrich Congenital Muscular Dystrophy: A Heterozygous In-Frame Deletion in the COL6A1 Gene Causes a Severe Phenotype","volume":"73","author":"Pan","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2024.102178_bib19","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1074\/jbc.M109932200","article-title":"Kinked Collagen VI Tetramers and Reduced Microfibril Formation as a Result of Bethlem Myopathy and Introduced Triple Helical Glycine Mutations","volume":"277","author":"Lamand\u00e9","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102178_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.22283","article-title":"Large Genomic Delitions: A novel cause of Ullrich Congenital Muscular Dystrophy","volume":"69","author":"Foley","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2024.102178_bib21","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1073\/pnas.121027598","article-title":"Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI","volume":"98","author":"Camacho Vanegas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102178_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ana.1120","article-title":"Frameshift mutation in the collagen VI gene causes Ullrich\u2019s disease","volume":"50","author":"Higuchi","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2024.102178_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.nmd.2007.03.017","article-title":"Variable penetrance of COL6A1 null mutations: Implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families","volume":"17","author":"Peat","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2024.102178_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.74","article-title":"SiRNA-mediated allele-specific silencing of a COL6A3 mutation in a cellular model of dominant ullrich muscular dystrophy","volume":"3","author":"Bolduc","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102178_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.omtn.2020.05.029","article-title":"Exon-skipping oligonucleotides restore functional collagen VI by correcting a common COL6A1 mutation in Ullrich congenital muscular dystrophy","volume":"21","author":"Aguti","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102178_bib26","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1038\/mtna.2014.22","article-title":"Allele-specific gene silencing of mutant mRNA restores cellular function in ullrich congenital muscular dystrophy fibroblasts","volume":"3","author":"Noguchi","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102178_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1089\/hum.2012.109","article-title":"Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy","volume":"23","author":"Gualandi","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2024.102178_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.omtn.2017.07.006","article-title":"Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy","volume":"8","author":"Marrosu","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102178_bib29","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.3390\/ijms23084410","article-title":"CRISPR\/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts","volume":"23","author":"L\u00f3pez-M\u00e1rquez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102178_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102178_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002248","article-title":"Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi","volume":"3","author":"Ohnishi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102178_bib32","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1086\/340608","article-title":"Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy","volume":"70","author":"Demir","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2024.102178_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.15252\/emmm.201707988","article-title":"Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy","volume":"10","author":"Trochet","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2024.102178_bib34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.omtn.2022.02.009","article-title":"Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy","volume":"27","author":"Trochet","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102178_bib35","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1172\/JCI130600","article-title":"Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models","volume":"129","author":"Morelli","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102178_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.118.036965","article-title":"Allele-Specific Silencing Ameliorates Restrictive Cardiomyopathy Attributable to a Human Myosin Regulatory Light Chain Mutation","volume":"140","author":"Zaleta-Rivera","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.omtn.2024.102178_bib37","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","article-title":"Designing siRNA that distinguish between genes that differ by a single nucleotide","volume":"2","author":"Schwarz","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2024.102178_bib38","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/brain\/awz139","article-title":"Allele-specific silencing as treatment for gene duplication disorders: Proof-of-principle in autosomal dominant leukodystrophy","volume":"142","author":"Giorgio","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2024.102178_bib39","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/nar\/gki312","article-title":"A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites","volume":"33","author":"Du","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102178_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejpn.2017.07.009","article-title":"Somatic mosaicism represents an underestimated event underlying collagen 6-related disorders","volume":"21","author":"D\u2019Amico","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.omtn.2024.102178_bib41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/humu.22691","article-title":"Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability","volume":"36","author":"Donkervoort","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2024.102178_bib42","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102178_bib43","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/nar\/gkp106","article-title":"A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity","volume":"37","author":"Bramsen","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102178_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.36","article-title":"5\u2032 unlocked nucleic acid modification improves siRNA targeting","volume":"2","author":"Snead","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102178_bib45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41467-018-02989-4","article-title":"Selection of GalNAc-conjugated siRNAs with limited off-Target-driven rat hepatotoxicity","volume":"9","author":"Janas","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102178_bib46","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.mt.6300240","article-title":"2\u2032-O-methyl-modified RNAs act as TLR7 antagonists","volume":"15","author":"Robbins","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102178_bib56","unstructured":"(2020). FDA press release on viltolarsen approval. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-targeted-treatment-rare-duchenne-muscular-dystrophy-mutation."},{"key":"10.1016\/j.omtn.2024.102178_bib52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nsmb780","article-title":"Kinetic analysis of the RNAi enzyme complex","volume":"11","author":"Haley","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102178_bib53","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1101\/gad.1187904","article-title":"RISC is a 5\u2032 phosphomonoester-producing RNA endonuclease","volume":"18","author":"Martinez","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2024.102178_bib54","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs meditae RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102178_bib55","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.omtn.2020.12.027","article-title":"Targeting the 5\u2032 untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy","volume":"23","author":"Winkelsas","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T16:47:02Z","timestamp":1718124422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2162253124000659"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102178","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"102178"}}